Skip to main content

Table 2 Summary of clinical data of patients with ODG and OAC, and immunohistochemistry of their tumors.

From: Id4 and FABP7 are preferentially expressed in cells with astrocytic features in oligodendrogliomas and oligoastrocytomas

Tumor ID

Diagnosis

Alive/Dead4

Survival Time (year)5

GFAP

FABP7

Id4

2650

ODG III1

A

9.12

- (MG+)6

- (MG+)

- (MG+)

2963

ODG III

A

7.28

- (MG+)

- (MG+)

- (MG+)

3081

ODG III

A

6.97

- (MG+)

- (MG+)

- (MG+)

3474*

ODG III

A

5.67

+ (?)7

-

-

3492

ODG III

D

5.29

-

-

-

3551*

ODG III

A

5.42

NI8

-

-

3607

ODG III

D

3.91

-

-

-

3651*

ODG III

A

5.09

-

-

-

3767

ODG III

A

4.73

-

-

-

3768

ODG III

A

4.73

-

-

-

3815

ODG III

A

4.59

- (MG+)

-/+9 (MG-)

- (MG-)

4115

ODG III

A

3.64

- (MG+)

- (MG+)

- (MG+)

4142

ODG III

A

3.55

- (MG+)

- (MG-)

- (MG-)

4167

ODG III

A

3.48

-/+

-/+

-

4253

ODG III

A

3.26

-

-

-

2450

OAC III2

A

9.9

+

+ (cyto/nuc)10

+ (cyto)

2459

OAC III

A

9.9

+

+ (cyto/nuc)

+ (cyto)

2533*

OAC III

A

6.55

+

+ (cyto)

-

2609*

OAC III

A

9.27

+

+ (cyto/nuc)

-

2622*

OAC III

D

5.75

+

-

-

2668

OAC III

D

8.97

+

+ (cyto/nuc)

+ (cyto)

3304

OAC III

A

6.27

+

+ (cyto)

+ (cyto)

3378

OAC III

A

5.97

+

+ (cyto/nuc)

+ (cyto/nuc)

3729

OAC II3

A

4.85

+

+ (cyto)

-

4141

OAC III

A

3.55

+

-

-

  1. 1 ODG III, oligodendroglioma, grade III.
  2. 2 OAC III, oligoastrocytoma, grade III.
  3. 3 OAC II, oligoastrocytoma, grade II.
  4. 4 Alive or dead of the patients was determined by the date of the most recent follow-up (9/30/04).
  5. 5 The date of diagnosis to 9/30/04 was defined as the survival time for patients who were alive.
  6. 6 Positive in microgemistocytes (MG).
  7. 7 This was a frozen section with 50% of tumor cells positive for GFAP, but H & E did not show microgemistocytes; the result was therefore questionable.
  8. 8 This was a frozen section with lots of freezing artifect; the result was not interpretable.
  9. 9 A small group (<5%) of tumor nuclei were positive.
  10. 10 Both cytoplasm and nuclei were positive.
  11. * Specimens that have been analyzed by cDNA microarrays.